Pancreatic Diseases 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pancreatic Diseases
NCT00962520: Tarceva With Chemoradiation and Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Checkmark ASCO-GI 2013
Jan 2013 - Jan 2013: ASCO-GI 2013
Checkmark P2 data
Nov 2011 - Nov 2011: P2 data
Active, not recruiting
2
40
US
Erlotinib, Tarceva, capecitabine, Xeloda, Radiation Therapy, gemcitabine, Gemzar, erlotinib
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Genentech, Inc.
Pancreatic Cancer
04/22
04/23

Download Options